Neuropeptides and migraine--a useful biological marker?

Neuropeptides and migraine--a useful biological marker? Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Neuropeptides and migraine--a useful biological marker? Abstract Text:

V Gallai,P Sarchielli,A Floridi,M Franceschini,M Codini,G Glioti,A Trequattrini,R Palumbo,

Neuropeptides and migraine--a useful biological marker? Publishing Authors By Initials

V Gallai,P Sarchielli,A Floridi,M Franceschini,M Codini,G Glioti,A Trequattrini,R Palumbo,

For similar peptides: neuropeptides research abstracts see: peptides: neuropeptides research

PUBMED ID PMID:

MEDLINE DATE:

Neuropeptides and migraine--a useful biological marker? Journal Published:

PUBLICATION TYPE: Editorial

Journal: Cephalalgia : an international journal of headache

VOLUME: 15

Page Numbers: 333-4

Journal Abbreviation: Cephalalgia

ISSN: 0333-1024

DAY: 11

MONTH: Oct

YEAR: 1995

Neuropeptides and migraine--a useful biological marker? Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8200710

Neuropeptides and migraine--a useful biological marker? Keywords Mesh Terms:

KEYWORDS: Neuropeptides

MESH TERMS: analysis

Chemical & Substance for Abstract: Neuropeptides and migraine--a useful biological marker? Information

Substance Name: Neurokinin A

Registry Number: 86933-74-6

Grant and Affiliation Information for Neuropeptides and migraine--a useful biological marker?

AFFILIATION:

Country: NORWAY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cephalalgia

REFSOURCE: Cephalalgia. 1995 Oct;15(5):384-90

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Neuropeptides and migraine--a useful biological marker? Related Publications

• Abnormal blink reflex studies in a patient with supraorbital neuralgia.
• Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat.
• Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?
• Benign cough headache.
• Bilateral paroxysmal hemicrania or bilateral paroxysmal cephalalgia, another novel indomethacin-responsive primary headache syndrome?
• Calcitonin gene-related peptide (CGRP) antagonists and migraine: is this a new era?
• Chronic headache and pituitary tumors.
• Cluster headache: new perspectives.
• Diffusion- and perfusion-weighted MR imaging in persistent migrainous visual disturbances.
• Dopamine and migraine: biology and clinical implications.
• Familial SUNCT.
• How do the currently used prophylactic agents work in migraine?
• Is a central action of acute antimigraine drugs essential?
• Migraine management: contrasting patient preferences with current clinical end points: introduction.
• Neuropeptides and migraine--a useful biological marker?
• Neuropeptides in migraine and cluster headache.
• Neurostimulation in primary headache syndromes.
• Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine.
• Octreotide is not effective in the acute treatment of migraine.
• Paroxysmal hemicrania in a family.
• Paroxysmal hemicrania: a prospective clinical study of 31 cases.
• Placebo response in cluster headache trials: a review.
• Rizatriptan in acute treatment of migraine: update on new comparative data.
• SUNCT syndrome in the elderly.
• The mode of action of sumatriptan is vascular? A debate.
• The paroxysmal hemicrania-tic syndrome.
• Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
• Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias.
• Update on the prophylaxis of migraine.
• What is the physiological role of the trigeminovascular system?